Gene · 6329
Papers1,928
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 1,928
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inferring Pathways of Oxidative Folding from Prefolding Free Energy Landscapes of Disulfide-Rich Toxins. | J Phys Chem B | 2023 | 36791259 | PubTator, text mining | PubMed |
| Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma. | Comput Math Methods Med | 2023 | 36785674 | PubTator, text mining | PubMed |
| Muscle fat replacement and contractility in patients with skeletal muscle sodium channel disorders. | Sci Rep | 2023 | 36782059 | PubTator, text mining | PubMed |
| Gene panel analysis of 119 index patients with suspected periodic paralysis in Japan. | Front Neurol | 2023 | 36779057 | PubTator, text mining | PubMed |
| Sigma-1 Receptor Signaling: In Search of New Therapeutic Alternatives for Cardiovascular and Renal Diseases. | Int J Mol Sci | 2023 | 36768323 | PubTator, text mining | PubMed |
| The Antidepressant Paroxetine Reduces the Cardiac Sodium Current. | Int J Mol Sci | 2023 | 36768229 | PubTator, text mining | PubMed |
| Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates. | Cancers (Basel) | 2023 | 36765727 | PubTator, text mining | PubMed |
| A novel heterozygous ATP1A2 pathogenic variant in a Chinese child with MELAS-like alternating hemiplegia. | Mol Genet Genomic Med | 2023 | 36749827 | PubTator, text mining | PubMed |
| Sensitization of colonic nociceptors by IL-13 is dependent on JAK and p38 MAPK activity. | Am J Physiol Gastrointest Liver Physiol | 2023 | 36749569 | PubTator, text mining | PubMed |
| Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study. | Exp Neurol | 2023 | 36720299 | PubTator, text mining | PubMed |
| Retigabine suppresses loss of force in mouse models of hypokalaemic periodic paralysis. | Brain | 2023 | 36718088 | PubTator, text mining | PubMed |
| Cryo-EM structure of human voltage-gated sodium channel Nav1.6. | Proc Natl Acad Sci U S A | 2023 | 36696443 | PubTator, text mining | PubMed |
| Carbamazepine for Chronic Muscle Pain: A Retrospective Assessment of Indications, Side Effects, and Treatment Response. | Brain Sci | 2023 | 36672104 | PubTator, text mining | PubMed |
Characterization and Chemical Synthesis of Cm39 (α-KTx 4.8): A Scorpion Toxin That Inhibits Voltage-Gated K+ Channel KV1.2 and Small- and Intermediate-Conductance Ca2+-Activated K+ Channels KCa2.2 and KCa3.1. | Toxins (Basel) | 2023 | 36668861 | PubTator, text mining | PubMed |
| THC and CBD: Similarities and differences between siblings. | Neuron | 2023 | 36638804 | PubTator, text mining | PubMed |
| Calmodulin Mutations in Human Disease. | Channels (Austin) | 2023 | 36629534 | PubTator, text mining | PubMed |
| Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4. | Brain Dev | 2023 | 36628799 | PubTator, text mining | PubMed |
| Antinociceptive activity of doliroside B. | Pharm Biol | 2023 | 36628487 | PubTator, text mining | PubMed |
| Blockers of Skeletal Muscle Nav1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back. | Int J Mol Sci | 2023 | 36614292 | PubTator, text mining | PubMed |
| Hyperkalemic periodic paralysis with paramyotonia and the anaesthetic implications. | BMJ Case Rep | 2023 | 36596627 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6329/papers?page=12